During a 20-year period disseminated mycobacteriosis occurred in 11(1.1%) of a total of 1006 patients with severe hematologic disorders, with the frequency remaining almost unchanged. The diagnosis in three patients (27%) was made only at autopsy. Tuberculosis accounted for 64% of all cases. Female preponderance was seen with a male-to-female ratio of 3:8. The major factors associated with dissemination included immunosuppression, weight loss, old age, and diabetes mellitus. Fever was the most common clinical symptom. Chest X-ray abnormalities, hypoproteinemia, liver dysfunction, and hypoxemia were noted in most cases. The prognosis of tuberculosis depended mainly on early diagnosis and treatment, while that for the nontuberculous variety was largely influenced by the underlying disease. Thus, our findings indicated that clinicians must suspect disseminated mycobacteriosis especially in any febrile patient with recent pulmonary pathology on chest X-ray, so that an adequate trial of therapy can be provided.
myelofibrosis, and malignant reticulosis. Diagnosis of Disseminated Mycobacteriosis Disseminated mycobacteriosis was defined as isolation of mycobacteria from one site together with culture evidence and/or demonstration of granulomas with or without positive stains for acid-fast bacilli from a second anatomically distinct site; a miliary pattern on the chest roentgenogram together with culture evidence from at least one site; or positive blood cultures together with clinical manifestations that could be produced by the circulating mycobacteria. The term "miliary" was used to describe disseminated disease with numerous small lesions up to twice the size of a millet-seed . Tuberculosis was regarded as disease caused by Mycobacterium tuberculosis, identified with a positive niacin test , while nontuberculous mycobacteriosis referred to disease caused by niacin-negative mycobacteria , which were differentiated using Simplified Identification Tests for Mycobacteria (Kyokuto, Tokyo).
Results

Incidence of Disseminated Mycobacteriosis
During the 20-year period, active mycobacteriosis was documented in 20 (2 .0%) of a total of 1006 patients with severe hematologic disorders ( Table 1) . Disseminated infection occurred in 11 patients (55%) Table 1 Occurrence of active mycobacteriosis by hematologic disorder 1) Tuberculous adenitis was confined to lymph nodes in the neck 2) Pulmonary tuberculosis included concurrent disease of the pleura 3) This figure includes 29 patients with Hodgkin's disease , two of whom developed cervical lymphadenitis and miliary tuberculosis, respectively Table 2 ). The incidence of disseminated mycobacteriosis, however, was slightly but not significantly higher in the second period than in the first period (seven patients, or 2.1% vs. four patients, or 0.6%; X2=3.15, p<0.10).
Female preponderance in disseminated mycobacteriosis was seen with a significantly higher incidence among females (three of 610, 0.5% vs. eight of 396, 2.0%; X2=3.87, p<0.05).
The median age in the group with tuberculosis was 69 years, as compared with 48 years in the group with the nontuberculous variety, which coincided with the median age in the total population. Approach to Diagnosis Disseminated mycobacteriosis was diagnosed during life in eight (73%) of the 11 patients (tuberculosis and the nontuberculous variety in four each). All of them had antemortem culture evidence with or without chest X-ray abnormalities. Because of thrombocytopenia, biopsy of the lung and liver was performed in two patients, confirming recent granuloma formation with epithelioid cells. Bone marrow aspiration and biopsy were obtained from four patients, of whom three had culture and histopathologic evidence. On the other hand, miliary tuberculosis was diagnosed only at autopsy in three patients, who had been suspected of having Pneumocystis carinii pneumonia. In one patient, however, retrospective study revealed miliary mottling on chest X-ray. At autopsy, the bone marrow contained granulomas with positive stains for acid-fast bacilli in these patients.
Mycobacterial isolates
The mycobacteria isolated were M. tuberculosis (seven patients), Mycobacterium avium complex (two patients), and Mycobacterium chelonae and Mycobacterium aurum (one patient each). In seven of the eight patients diagnosed antemortem, the specimens yielding mycobacteria on culture were the sputum and/or gastric juice (six patients), and bone marrow (three patients), urine and bronchoalveolar lavage fluid (two patients each), and stool and pericardial effusion (one patient each). In the other patient with acute myelofibrosis who had a long-term intravenous catheter in place, conventional blood cultures yielded a rapidly growing Mycobacterium species, subsequently identified as M. aurum by courtesy of Drs. Hiroshi Murata and Michio Tsukamura, National Chubu Hospital, Obu. On the other hand, the three patients diagnosed postmortem had M. tuberculosis isolated from autopsy specimens (lung in two and hilar node in one). Drug sensitivity testing showed M. tuberculosis (five isolates) and M. aurum (one isolate) to be sensitive to at least three of the commonly used agents including streptomycin, isoniazid, rifampicin, ethambutol and p-aminosalicylic acid, whereas M. avium complex (two isolates) and M. chelonae (one isolate) were resistant to these agents. Incidentally, the M. aurum isolate proved sensitive by disk to gentamicin and cefoperazone. Host Factors Nine patients (82%) received immunosuppressive therapy with at least one antitumor agent for hematologic malignancy or high-dose methylprednisolone for severe aplastic anemia during the two months prior to diagnosis. The other two patients (chronic myelogenous leukemia and acute myelofibrosis in one each) remained untreated until death because of disseminated nontuberculous mycobacteriosis discovered at the time of admission.
Seven patients (64%) had diabetes mellitus prior to the diagnosis (five with tuberculosis and two with the nontuberculous variety). weight loss of 5kg (range, 1-9kg) during the three months prior to diagnosis. None of the patients presented with signs of meningeal or peritoneal irritation. Radiology: The chest roentgenogram showed miliary mottling in six patients (five with tuberculosis and one with the nontuberculous variety) ( Table 3) . Miliary M. chelonae disease occurred with chorioretinitis ( Fig. 1 ). Laboratory Tests: Both leukocyte and platelet counts were mostly governed by the underlying disease and/or its treatment. The median neutrophil count was 970/mm3 (range, 30-8550/mm3), while the median lymphocyte count was 330/mm3 (range, 30-1550/mm3). Monocytosis above 950/mm3 was noted in one patient. None of the patients showed coagulation abnormalities. Hypoproteinemia below 6.0g/dl was observed in seven patients (64%). Serum alkaline phosphatase and glutamic oxaloacetic transaminase determinations were elevated in eight patients (73%) each, but in most cases the elevations remained less than twofold above the normal range. Blood-gas analysis performed in nine patients revealed a decrease in arterial oxygen tension (median, 69mmHg; range, 51-81mmHg) with an increased alveolar-arterial oxygen gradient (median, 33mmHg; range, 22-50mmHg). Pulmonary function tests done in four patients disclosed a decrease in the diffusing capacity for carbon monoxide to less than 50% of normal. Tuberculin Test: The tuberculin test was performed in five patients (two with tuberculosis and three with the nontuberculous variety), all of whom had a history of positive results. Only one patient with severe aplastic anemia who developed M. avium complex infection was positive at the time of diagnosis. In one patient with non-Hodgkin's lymphoma who recovered from miliary tuberculosis, however, the skin test converted to positive six months post-treatment, although antitumor therapy proved ineffective.
Treatment and Outcome
In the seven patients with disseminated tuberculosis the median survival after the diagnosis was made was 12 days (range, 0-233 days). Two of the three patients who received standard antituberculous therapy for more than two weeks survived more than two months. On the other hand, in the four patients with the nontuberculous variety the median survival after the diagnosis was made was 117 days (range, 72-232 days). Three patients with nonbacteremic infection received triple antituberculous therapy6) despite the in vitro multiple drug resistance of the isolates. The other patient with M. aurum bacteremia was treated with gentamicin and cefoperazone, resulting in defervescence prior to removal of the intravenous catheter.
Discussion
The present study revealed the current status of disseminated mycobacteriosis in patients with severe hematologic disorders in Japan. During the 20-year period the disease occurred in 1.1% of this patient population, with the frequency remaining almost unchanged.
As many as 55% of our patients with active mycobacteriosis developed disseminated disease, reflecting host defenses impaired mainly by the underlying disease and/or its treatment, weight loss, old age and diabetes mellitus. Depressed cellular immunity7)-9) may play a major role in the infectious process with dissemination. Indeed, a decreased tuberculin skin reaction was observed in this series.
Seventy-three percent of our patients with disseminated mycobacteriosis were over 50 years of age. Miliary tuberculosis tended to occur mostly in the aged in contrast with the nontuberculous variety in younger adults. M. tuberculosis is generally considered more pathogenic than nontuberculous mycobacteria. This paradox therefore remains to be elucidated.
Miliary M. chelonae disease with ocular lesions was noted in this series. Miliary dissemination has been considered pathognomonic of M. tuberculosis infection. 
